Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Vor Biopharma
About
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
- Cambridge,Massachusetts,United States
- 101 - 250
- https://www.vorbio.com
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $115.80M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Stock Symbol
- nasdaq:VOR
- Legal Name
- Vor Biopharma Inc.
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells. Cell surface-targeted immunotherapies, such as bispecific antibodies, antibody-drug conjugates, and chimeric antigen receptor (CAR) T cells, generally target both cancer and normal cells, causing substantial toxicities and limiting their potential. The company is taking a fundamentally novel approach to targeting cancer selectively by developing hematopoietic stem cells (HSCs) that have been engineered to be protected from specifically targeted immunotherapies. These HSCs are designed to generate healthy, functional cells that are also protected from depletion by cancer-targeted therapies.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 7, 2022 | Post-IPO Equity | $115.80M | 1 |
RA Capital Management
|
— | Detail |
| Feb 5, 2021 | IPO | $176.90M | — | — | — | Detail |
| Jul 7, 2020 | Series B | $110M | 8 |
RA Capital Management
|
— | Detail |
| Feb 14, 2019 | Series A | $42M | 5 |
5AM Ventures
RA Capital Management
|
— | Detail |
Investors
Employee Profiles
